Peter Kreutzmann

1.0k total citations
20 papers, 837 citations indexed

About

Peter Kreutzmann is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Kreutzmann has authored 20 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cell Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Kreutzmann's work include Skin and Cellular Biology Research (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Peter Kreutzmann is often cited by papers focused on Skin and Cellular Biology Research (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Peter Kreutzmann collaborates with scholars based in Germany, United Kingdom and Canada. Peter Kreutzmann's co-authors include Hans‐Jürgen Mägert, Wolf‐Georg Forssmann, Ludger Ständker, M. Reinecke, Hans Fritz, Michael Walden, Ute C. Marx, Gerald Wolf, Detlef Siemen and Jeannette Kluess and has published in prestigious journals such as Journal of Biological Chemistry, Nano Letters and PLoS ONE.

In The Last Decade

Peter Kreutzmann

20 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kreutzmann Germany 14 384 205 105 102 89 20 837
Motoki Tamai Japan 9 560 1.5× 152 0.7× 94 0.9× 15 0.1× 91 1.0× 31 1.2k
James Fernandez United States 14 812 2.1× 258 1.3× 54 0.5× 41 0.4× 236 2.7× 24 1.3k
Sojin Shikano United States 17 918 2.4× 144 0.7× 156 1.5× 39 0.4× 455 5.1× 34 1.6k
Andreá Schneider Germany 19 521 1.4× 69 0.3× 51 0.5× 61 0.6× 338 3.8× 31 1.2k
Ming Chiu Fung Hong Kong 14 414 1.1× 102 0.5× 48 0.5× 8 0.1× 135 1.5× 26 725
M. C. Fung Hong Kong 21 560 1.5× 37 0.2× 109 1.0× 17 0.2× 479 5.4× 45 1.6k
Kaori Asamitsu Japan 23 782 2.0× 115 0.6× 29 0.3× 159 1.6× 340 3.8× 39 1.4k
James Aylward Australia 15 438 1.1× 108 0.5× 82 0.8× 105 1.0× 50 0.6× 27 873
Victor Boyartchuk United States 20 820 2.1× 152 0.7× 79 0.8× 6 0.1× 210 2.4× 27 1.3k
Carsten Röpke Denmark 19 357 0.9× 31 0.2× 57 0.5× 107 1.0× 510 5.7× 38 1.2k

Countries citing papers authored by Peter Kreutzmann

Since Specialization
Citations

This map shows the geographic impact of Peter Kreutzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kreutzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kreutzmann more than expected).

Fields of papers citing papers by Peter Kreutzmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kreutzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kreutzmann. The network helps show where Peter Kreutzmann may publish in the future.

Co-authorship network of co-authors of Peter Kreutzmann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kreutzmann. A scholar is included among the top collaborators of Peter Kreutzmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kreutzmann. Peter Kreutzmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagnon, Marilou, et al.. (2019). International Consensus Statement on the Role of Nurses in Supervised Consumption Sites. 3(1). e22–e31. 3 indexed citations
2.
Schönfeld, Peter, Detlef Siemen, Peter Kreutzmann, Claudia Franz, & Lech Wojtczak. (2013). Interaction of the antibiotic minocycline with liver mitochondria - role of membrane permeabilization in the impairment of respiration. FEBS Journal. 280(24). 6589–6599. 13 indexed citations
3.
Weber, John T., Durk Fekkes, Angela S. Vlug, et al.. (2012). Potential neuroprotective effects of oxyresveratrol against traumatic injury. European Journal of Pharmacology. 680(1-3). 55–62. 44 indexed citations
4.
Angenstein, Frank, Jürgen Goldschmidt, Peter Kreutzmann, et al.. (2012). Toxoplasma gondii Actively Inhibits Neuronal Function in Chronically Infected Mice. PLoS ONE. 7(4). e35516–e35516. 74 indexed citations
5.
Kreutzmann, Peter, et al.. (2010). Minocycline Recovers MTT-Formazan Exocytosis Impaired by Amyloid Beta Peptide. Cellular and Molecular Neurobiology. 30(7). 979–984. 10 indexed citations
6.
Diesing, Anne‐Kathrin, Constanze Nossol, Patricia Panther, et al.. (2010). Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2. Toxicology Letters. 200(1-2). 8–18. 117 indexed citations
7.
Kreutzmann, Peter, et al.. (2009). Impairment of mitochondrial function by minocycline. FEBS Journal. 276(6). 1729–1738. 30 indexed citations
8.
Lorenz, Peter, et al.. (2008). Hydroxy-1-aryl-isochromans: protective compounds against lipid peroxidation and cellular nitrosative stress. Redox Report. 13(1). 23–30. 6 indexed citations
9.
Wolf, Gerald, et al.. (2008). Inhibitory modulation of the mitochondrial permeability transition by minocycline. Biochemical Pharmacology. 77(5). 888–896. 44 indexed citations
10.
Lauber, Thomas, Peter Kreutzmann, Axel Schulz, et al.. (2007). LEKTI domain 15 is a functional Kazal-type proteinase inhibitor. Protein Expression and Purification. 57(1). 45–56. 7 indexed citations
11.
Fatima, Ambrin, et al.. (2007). Minocycline, a possible neuroprotective agent in Leber’s hereditary optic neuropathy (LHON): Studies of cybrid cells bearing 11778 mutation. Neurobiology of Disease. 28(3). 237–250. 26 indexed citations
12.
Manzanera, Maximino, Daniel Frankel, Haitao Li, et al.. (2006). Macroscopic 2D Networks Self-Assembled from Nanometer-Sized Protein/DNA Complexes. Nano Letters. 6(3). 365–370. 6 indexed citations
13.
Egelrud, T, Maria Brattsand, Peter Kreutzmann, et al.. (2005). hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. British Journal of Dermatology. 153(6). 1200–1203. 93 indexed citations
14.
Kreutzmann, Peter, Arthur R. Schulz, Ludger Ständker, Wolf‐Georg Forssmann, & Hans‐Jürgen Mägert. (2003). Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor. Journal of Chromatography B. 803(1). 75–81. 31 indexed citations
15.
Walden, Michael, et al.. (2002). Biochemical Features, Molecular Biology and Clinical Relevance of the Human 15-Domain Serine Proteinase Inhibitor LEKTI. Biological Chemistry. 383(7-8). 1139–1141. 16 indexed citations
16.
Hà, Chu Hoàng, et al.. (2002). Identification and properties of type I‐signal peptidases of Bacillus amyloliquefaciens. European Journal of Biochemistry. 269(2). 458–469. 17 indexed citations
17.
Mägert, Hans‐Jürgen, et al.. (2002). LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance. The International Journal of Biochemistry & Cell Biology. 34(6). 573–576. 43 indexed citations
18.
Mägert, Hans‐Jürgen, Peter Kreutzmann, Ludger Ständker, et al.. (2002). The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.. PubMed. 7(2). 49–56. 28 indexed citations
19.
Lauber, Thomas, Ute C. Marx, Axel Schulz, et al.. (2001). Accurate Disulfide Formation in Escherichia coli: Overexpression and Characterization of the First Domain (HF6478) of the Multiple Kazal-Type Inhibitor LEKTI. Protein Expression and Purification. 22(1). 108–112. 28 indexed citations
20.
Mägert, Hans‐Jürgen, Ludger Ständker, Peter Kreutzmann, et al.. (1999). LEKTI, a Novel 15-Domain Type of Human Serine Proteinase Inhibitor. Journal of Biological Chemistry. 274(31). 21499–21502. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motoki Tamai Breakdown of academic impact, for papers by James Fernandez Breakdown of academic impact, for papers by Sojin Shikano Breakdown of academic impact, for papers by Andreá Schneider Breakdown of academic impact, for papers by Ming Chiu Fung Breakdown of academic impact, for papers by M. C. Fung Breakdown of academic impact, for papers by Kaori Asamitsu Breakdown of academic impact, for papers by James Aylward Breakdown of academic impact, for papers by Victor Boyartchuk Breakdown of academic impact, for papers by Carsten Röpke
Rankless by CCL
2026